Skip to content

Accuracy of Blood Loss Estimation After Vaginal Delivery

The Accuracy of Blood Loss Estimation After Simulated Vaginal Delivery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00462839
Enrollment
106
Registered
2007-04-19
Start date
2006-07-31
Completion date
2008-04-30
Last updated
2014-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Hemorrhage

Keywords

Estimated Blood Loss, Obstetrics, postpartum hemorrhage

Brief summary

Post-partum hemorrhage (PPH) is defined as blood loss greater than 500 mL after vaginal delivery. Delayed diagnosis of PPH is a major cause of maternal morbidity and mortality. Obstetricians estimate blood loss at delivery by visual estimation of blood collected in the obstetric drapes. Blood is often mixed with urine and surgical sponges. The urine, blood, and sponges collect in a cone shaped plastic bag that is suspended from the perineum during delivery. Visual estimation of blood loss is insensitive in diagnosing PPH. In one study visual assessment of blood loss underestimated postpartum blood loss by 33% to 50% compared to an objective measurement of blood loss using photospectrometry. Other studies have shown that the magnitude of underestimation increases as the amount of blood loss is increased. A limitation of previous studies is that there is no gold standard for blood loss determination in the third stage of labor. Care providers (obstetricians, anesthesiologists, and labor & delivery nurses) need to be able to accurately estimate blood loss in order to better care for mothers and prevent morbidity and mortality. It is unknown whether provider type or experience (obstetric and anesthesiology resident, fellow, attending physicians, and nurses) influences the accuracy of blood loss estimation, or whether blood loss estimation can be improved by providing graduated markings on the vaginal delivery drape.

Detailed description

Packed red blood cells discarded by the blood bank will be mixed with normal saline to simulate whole blood with a hematocrit of 33%. A total of eight isolated study stations will be set up (study participants will only be able to visualize the vaginal delivery drape for one station at a time). The simulated blood will be mixed with urine and sponges and be placed in suspended blood collection drapes which are used during vaginal deliveries at Northwestern Memorial Hospital. Two types of drapes will be used: drapes without calibrated markings and drapes with calibrated markings. Calibrated volume markings will begin at 500 mL at 500 mL intervals to 2500 mL. Study participants will be randomized to one of two groups. Randomization will occur in blocks depending on provider type. Group 1 will view the unmarked vaginal collection drapes first and Group 2 will view the collection drapes with the calibrated markings first. Both groups will analyze the initial four study stations in random order. At the completion of the four study stations, the group which evaluated the drapes without markings will cross over to view the stations with calibrated markings and the group that views uncalibrated drapes will then view the calibrated drapes. Each study participant will view a station and write his/her estimation of blood loss on a data card. Study participants will NOT be allowed to change answers once they have been recorded. Demographic data on study participants will include provider type, level of training/years of practice, and gender.

Interventions

PROCEDUREblood loss estimation

Participants were randomized in blocks, by provider type to view either the four calibrated stations or the four non-calibrated stations. The order of the volumes within each set of stations was randomized. Participants received a data card for each station on which they wrote the volume estimated. After each station, the data card was collected. Alterations to the estimations were not allowed once the answers were recorded. Subjects were then crossed over to the other group and asked to estimate the blood volumes in the non-calibrated drapes if they had first viewed the calibrated drape or the calibrated drape if they had viewed the non-calibrated drape. The order of viewing the four volumes was again randomized. The volumes were the same at the corresponding station for the calibrated and non-calibrated stations so the impact of the calibration markings on accuracy could be determined.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Any anesthesia or obstetric attending or resident may participate provided that they have rotated through obstetrics/obstetric anesthesia.

Exclusion criteria

* Any provider that does not complete all of the stations will be excluded from analysis. Any participant who chooses to withdraw from the study will also be excluded from the analysis.

Design outcomes

Primary

MeasureTime frameDescription
Difference in Actual Blood Volume and Estimated Blood Volume in Milliliters.1 hourTwo types of drapes were used: drapes with and without volume calibrations. Calibrated drapes had volume markings beginning at 500ml with 500ml increments to a total of 2500ml. The participants were asked to estimate the volume contained in the bag and the difference in milliliters between the estimate and actual volume was calculated.

Secondary

MeasureTime frame
Number and Type of Care Providers Assigned to Study Arms.1 hour
Level of Training1 hour
Number of Years of Clinical Experience Providing Patient Care Requiring Blood Loss Estimation.1 hour

Countries

United States

Participant flow

Recruitment details

The study was conducted on two separate dates at Prentice Women's Hospital. Eight stations were set up in 8-12 hour periods in an empty labor and delivery room. Participants were randomized in blocks by provider type. The order of the volumes was randomized. Subjects were not informed that the volumes in the two groups were the same.

Participants by arm

ArmCount
Calibrated Vaginal Delivery Drapes Viewed First
Calibrated drapes had volume markings beginning at 500ml with 500ml increments to a total of 2500ml. Subjects were randomized to either view calibrated or uncalibrated (standard of care) drapes and asking to estimated volume of blood loss. Subjects were then crossed over and experiment repeated.
53
Noncalibrated Drapes Viewed First
No distinguishable volume markings on drape (standard of care). Subjects were randomized to either view calibrated or uncalibrated (standard of care) drapes and asking to estimated volume of blood loss. Subjects were then crossed over and experiment repeated.
53
Total106

Baseline characteristics

CharacteristicCalibrated Vaginal Delivery Drapes Viewed FirstNoncalibrated Drapes Viewed FirstTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
53 Participants53 Participants106 Participants
Region of Enrollment
United States
53 participants53 participants106 participants
Sex: Female, Male
Female
34 Participants32 Participants66 Participants
Sex: Female, Male
Male
19 Participants21 Participants40 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 530 / 53
serious
Total, serious adverse events
0 / 530 / 53

Outcome results

Primary

Difference in Actual Blood Volume and Estimated Blood Volume in Milliliters.

Two types of drapes were used: drapes with and without volume calibrations. Calibrated drapes had volume markings beginning at 500ml with 500ml increments to a total of 2500ml. The participants were asked to estimate the volume contained in the bag and the difference in milliliters between the estimate and actual volume was calculated.

Time frame: 1 hour

Population: per protocal

ArmMeasureGroupValue (MEAN)
Calibrated Vaginal Delivery Drapes Viewed FirstDifference in Actual Blood Volume and Estimated Blood Volume in Milliliters.300 ml-20.8 milliliters
Calibrated Vaginal Delivery Drapes Viewed FirstDifference in Actual Blood Volume and Estimated Blood Volume in Milliliters.500 ml-53.5 milliliters
Calibrated Vaginal Delivery Drapes Viewed FirstDifference in Actual Blood Volume and Estimated Blood Volume in Milliliters.1000 ml-32.8 milliliters
Calibrated Vaginal Delivery Drapes Viewed FirstDifference in Actual Blood Volume and Estimated Blood Volume in Milliliters.2000 ml-178 milliliters
Noncalibrated Drapes Viewed FirstDifference in Actual Blood Volume and Estimated Blood Volume in Milliliters.2000 ml-829.8 milliliters
Noncalibrated Drapes Viewed FirstDifference in Actual Blood Volume and Estimated Blood Volume in Milliliters.300 ml-41.7 milliliters
Noncalibrated Drapes Viewed FirstDifference in Actual Blood Volume and Estimated Blood Volume in Milliliters.1000 ml-145.3 milliliters
Noncalibrated Drapes Viewed FirstDifference in Actual Blood Volume and Estimated Blood Volume in Milliliters.500 ml-96.0 milliliters
Comparison: Repeated measures ANOVA comparing all levels of blood estimation (P=0.0002). Post-hoc comparisons using Bonferroni corrects t-tests.p-value: <0.05ANOVA
Secondary

Level of Training

Time frame: 1 hour

ArmMeasureGroupValue (NUMBER)
Calibrated Vaginal Delivery Drapes Viewed FirstLevel of TrainingAttending physician19 participants
Calibrated Vaginal Delivery Drapes Viewed FirstLevel of TrainingResident physician22 participants
Calibrated Vaginal Delivery Drapes Viewed FirstLevel of TrainingNurse12 participants
Noncalibrated Drapes Viewed FirstLevel of TrainingAttending physician22 participants
Noncalibrated Drapes Viewed FirstLevel of TrainingResident physician22 participants
Noncalibrated Drapes Viewed FirstLevel of TrainingNurse9 participants
p-value: 0.72Chi-squared, Corrected
Secondary

Number and Type of Care Providers Assigned to Study Arms.

Time frame: 1 hour

Population: per protocol

ArmMeasureGroupValue (NUMBER)
Calibrated Vaginal Delivery Drapes Viewed FirstNumber and Type of Care Providers Assigned to Study Arms.Anesthesia21 participants
Calibrated Vaginal Delivery Drapes Viewed FirstNumber and Type of Care Providers Assigned to Study Arms.Obstetrics20 participants
Calibrated Vaginal Delivery Drapes Viewed FirstNumber and Type of Care Providers Assigned to Study Arms.Nursing12 participants
Noncalibrated Drapes Viewed FirstNumber and Type of Care Providers Assigned to Study Arms.Anesthesia22 participants
Noncalibrated Drapes Viewed FirstNumber and Type of Care Providers Assigned to Study Arms.Obstetrics22 participants
Noncalibrated Drapes Viewed FirstNumber and Type of Care Providers Assigned to Study Arms.Nursing9 participants
p-value: 0.76Chi-squared, Corrected
Secondary

Number of Years of Clinical Experience Providing Patient Care Requiring Blood Loss Estimation.

Time frame: 1 hour

ArmMeasureGroupValue (NUMBER)
Calibrated Vaginal Delivery Drapes Viewed FirstNumber of Years of Clinical Experience Providing Patient Care Requiring Blood Loss Estimation.< 5 years30 participants
Calibrated Vaginal Delivery Drapes Viewed FirstNumber of Years of Clinical Experience Providing Patient Care Requiring Blood Loss Estimation.5-10 years11 participants
Calibrated Vaginal Delivery Drapes Viewed FirstNumber of Years of Clinical Experience Providing Patient Care Requiring Blood Loss Estimation.> 10 years12 participants
Noncalibrated Drapes Viewed FirstNumber of Years of Clinical Experience Providing Patient Care Requiring Blood Loss Estimation.< 5 years29 participants
Noncalibrated Drapes Viewed FirstNumber of Years of Clinical Experience Providing Patient Care Requiring Blood Loss Estimation.5-10 years13 participants
Noncalibrated Drapes Viewed FirstNumber of Years of Clinical Experience Providing Patient Care Requiring Blood Loss Estimation.> 10 years11 participants
p-value: 0.89Chi-squared, Corrected

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026